B. Marchou - Concepedia

Author

B. Marchou

Also Known As

A. Calmy, B Marchou, B. MARCHOU, B. Marchou, Bruno Marchou, C Le Pendeven, C. Le Pendeven, Houcine Bentayeb, J Journe, J-L Vildé

246

Publications

5.8K

Citations

H-Index

102

Concepts

All Affiliations

Inserm Hôpital Purpan Centre Hospitalier Universitaire de Toulouse Université Toulouse III - Paul Sabatier Université Fédérale de Toulouse Midi-Pyrénées

About

B. Marchou is an author at Inserm specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	37	1.8K
2	Health Sciences	6	6	188
3	Public Health	4	4	291
4	Biochemistry	1	1	46
5	Biostatistics	1	1	55

B. Marchou

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M. tuberculosis Persistence Pascale Peyron, Julien Vaubourgeix, Yannick Poquet, PLoS Pathogens	2008	713
Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? Jean‐Michel Mansuy, M. Dutertre, Catherine Mengelle, The Lancet Infectious Diseases InfertilityPathogenesisGynecologyVirologySemen Analysis	2016	380
Zika virus in semen and spermatozoa Jean‐Michel Mansuy, Elsa Suberbielle, Sabine Chapuy‐Regaud, The Lancet Infectious Diseases InfertilityAndrologyFertilityVirologyMale Infertility	2016	171
Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals Maud Mavigner, Michelle Cazabat, Martine Dubois, Journal of Clinical Investigation	2011	170
Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism Stéphanie Raymond, Pierre Delobel, Maud Mavigner, AIDS	2008	127
HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy Maud Mavigner, Pierre Delobel, Michelle Cazabat, PLoS ONE	2009	124
Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Marianne Savès, François Raffi, Philippe Clevenbergh, Antimicrobial Agents and Chemotherapy	2000	115
R5 to X4 Switch of the Predominant HIV-1 Population in Cellular Reservoirs During Effective Highly Active Antiretroviral Therapy Pierre Delobel, Karine Sauné, Michelle Cazabat, JAIDS Journal of Acquired Immune Deficiency Syndromes Cellular ReservoirsHiv-1 Coreceptor UsageHuman RetrovirusImmunologyCoreceptor Usage	2005	114
Correlates of late HIV diagnosis: implications for testing policy Cyrille Delpierre, Rosemary Dray‐Spira, Lise Cuzin, International Journal of STD & AIDS	2007	110
Total Body Composition by DXA of 241 HIV-Negative Men and 162 HIV-Infected Men É. Bonnet, Cyrille Delpierre, Agnès Sommet, Journal of Clinical Densitometry Total Body CompositionSexual HealthHiv-infected MenBody CompositionHiv-negative Men	2005	88

Page 1